Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Profit After Tax: 2015-2024

Historic Profit After Tax for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to -$237.1 million.

  • Editas Medicine's Profit After Tax rose 59.58% to -$25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$199.8 million, marking a year-over-year increase of 5.10%. This contributed to the annual value of -$237.1 million for FY2024, which is 54.74% down from last year.
  • As of FY2024, Editas Medicine's Profit After Tax stood at -$237.1 million, which was down 54.74% from -$153.2 million recorded in FY2023.
  • Editas Medicine's Profit After Tax's 5-year high stood at -$116.0 million during FY2020, with a 5-year trough of -$237.1 million in FY2024.
  • For the 3-year period, Editas Medicine's Profit After Tax averaged around -$203.6 million, with its median value being -$220.4 million (2022).
  • In the last 5 years, Editas Medicine's Profit After Tax plummeted by 65.98% in 2021 and then soared by 30.49% in 2023.
  • Yearly analysis of 5 years shows Editas Medicine's Profit After Tax stood at -$116.0 million in 2020, then crashed by 65.98% to -$192.5 million in 2021, then dropped by 14.51% to -$220.4 million in 2022, then skyrocketed by 30.49% to -$153.2 million in 2023, then tumbled by 54.74% to -$237.1 million in 2024.